Exploratory Lapatinib (Positron Emission Tomography) PET Study in Subjects With Breast Cancer

NCT01290354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Lapatinib
DRUG: [11C] lapatinib

Sponsor

GlaxoSmithKline